InvestorsHub Logo

lakingsphan0427

11/09/17 5:17 PM

#3119 RE: H2R #3116

H2R did you buy DVAX? Their Heplisav-B vaccine got approved today.. Up over $2 AH.. Stock will be in the mid $30 next year..

EXEL, DVAX, ARTH are my biotech winners this year and of course my losers are AGEN and KERX.. I am regretting about AGEN the most.. arrrgh